FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to compounds of formula
, where Y represents carbonic acid, or its amide or ether, containing from 0 to 12 carbon atoms; A represents -(CH2)6-, cys-CH2CH=CH-(CH2)3- or -CH2C=C-(CH2)3- where 1 or 2 carbon atoms can be substituted by O; or A represents -(CH2)m-Ar-(CH2)0-, where Ar represents unsubstituted phenyl, thienyl or thiazolyl, sum of m and o constitutes from 1 to 4, and where one CH2 can be substituted by O; X represents CHCl; R represents group hydrocarbyl or hydroxy hydrocarbyl, containing from 1 to 12 carbon atoms; D represents hydrogen; and n represents integer number from 3 to 4. Also described are ophthalmologically acceptable liquids based on such compounds.
EFFECT: compounds are selective agonists of prostaglandin EP2 and can be useful for treatment of glaucoma or for reduction of intraocular pressure.
27 cl, 2 ex, 4 tbl, 27 dwg
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 10,10-DIALKYLPROSTANIC ACID USED FOR INTRAOCULAR DECOMPRESSION | 2004 |
|
RU2336081C2 |
SUBSTITUTED CYCLOPENTANS POSSESSING PROSTAGLANDIN ACTIVITY | 2008 |
|
RU2481339C2 |
THERAPEUTIC COMPOUNDS | 2009 |
|
RU2500674C2 |
THERAPEUTIC SUBSTITUTED CYCLOPENTANES | 2009 |
|
RU2501789C2 |
SUBSTITUTED CYCLOPENTANES, POSSESSING PROSTAGLANDIN ACTIVITY | 2009 |
|
RU2505530C2 |
DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES AND RESPIRATORY WAYS DISEASES | 2001 |
|
RU2265011C2 |
METHOD OF TREATMENT OF DISEASES AT MAMMALS | 2004 |
|
RU2344121C2 |
METHOD OF TREATMENT OF SCHIZOPHRENIA | 2012 |
|
RU2648474C2 |
CYCLOPENTANE COMPOUNDS | 2019 |
|
RU2794997C2 |
COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
Authors
Dates
2012-01-10—Published
2005-12-08—Filed